Literature DB >> 9606994

NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.

S Kim1, W M Yokoyama.   

Abstract

MHC class I-specific NK cell receptors inhibit natural killing, and presumably granule exocytosis, when engaged by target cell ligands but it is not yet known which specific activation receptor pathway for natural killing is inhibited or if these receptors influence other NK cell activities such as cytokine production. Moreover, an individual NK cell may express multiple inhibitory MHC class I receptors; these NK cell receptors may cooperate in inhibiting NK cell activity. To address these issues, we examined whether the murine Ly-49A NK cell receptor, specific for H-2Dd, can regulate granule exocytosis and NK cell cytokine responses. Expression of transfected H-2Dd on tumor targets specifically inhibited granule release from Ly-49A+ NK cells. Importantly, Ly-49A engagement also inhibited target cell-induced cytokine (GM-CSF) secretion. Using a target cell-free system, we next determined that anti-Ly49A mAb can regulate NK cell responses induced by specific stimuli. Cross-linking of NK1.1 with immobilized mAb induced granule release and TNF-alpha, IFN-gamma, and GM-CSF secretion; all were inhibited by coimmobilized anti-Ly-49A. These effects were specific because an isotype-matched control mAb did not alter NK1.1-mediated responses. Therefore, these results demonstrate that the Ly-49A receptor can regulate granule exocytosis and cytokine secretion in response to targets and NK1.1 signaling, consistent with its function as an inhibitory receptor for MHC class I molecules in NK cell-mediated cytotoxicity. In addition, these results strongly support the thesis that signals transduced from Ly-49A alone are sufficient for mediating the inhibitory effects against target cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9606994     DOI: 10.1006/cimm.1998.1252

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  9 in total

Review 1.  Stromal-cell regulation of natural killer cell differentiation.

Authors:  Claude Roth; Carla Rothlin; Sylvain Riou; David H Raulet; Greg Lemke
Journal:  J Mol Med (Berl)       Date:  2007-04-11       Impact factor: 4.599

2.  Prenatal Allospecific NK Cell Tolerance Hinges on Instructive Allorecognition through the Activating Receptor during Development.

Authors:  Amir M Alhajjat; Beverly S Strong; Amanda E Lee; Lucas E Turner; Ram K Wadhwani; John R Ortaldo; Jonathan W Heusel; Aimen F Shaaban
Journal:  J Immunol       Date:  2015-07-01       Impact factor: 5.422

3.  In vivo natural killer cell activities revealed by natural killer cell-deficient mice.

Authors:  S Kim; K Iizuka; H L Aguila; I L Weissman; W M Yokoyama
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

4.  NKG2D receptor-mediated NK cell function is regulated by inhibitory Ly49 receptors.

Authors:  Jeyarani Regunathan; Yuhong Chen; Demin Wang; Subramaniam Malarkannan
Journal:  Blood       Date:  2004-08-24       Impact factor: 22.113

5.  Griscelli syndrome: characterization of a new mutation and rescue of T-cytotoxic activity by retroviral transfer of RAB27A gene.

Authors:  João C S Bizario; Jérôme Feldmann; Fabíola A Castro; Gaël Ménasché; Cristina M A Jacob; L Cristofani; Erasmo B Casella; Júlio C Voltarelli; Geneviève de Saint-Basile; Enilza M Espreafico
Journal:  J Clin Immunol       Date:  2004-07       Impact factor: 8.317

6.  Effects of MHC class I alleles on licensing of Ly49A+ NK cells.

Authors:  A Helena Jonsson; Liping Yang; Sungjin Kim; Samantha M Taffner; Wayne M Yokoyama
Journal:  J Immunol       Date:  2010-03-01       Impact factor: 5.422

7.  Nonstochastic coexpression of activation receptors on murine natural killer cells.

Authors:  H R Smith; H H Chuang; L L Wang; M Salcedo; J W Heusel; W M Yokoyama
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

8.  Functional dichotomy in natural killer cell signaling: Vav1-dependent and -independent mechanisms.

Authors:  F Colucci; E Rosmaraki; S Bregenholt; S I Samson; V Di Bartolo; M Turner; L Vanes; V Tybulewicz; J P Di Santo
Journal:  J Exp Med       Date:  2001-06-18       Impact factor: 14.307

9.  MHC class I expression protects rat colon carcinoma cells from hepatic natural killer cell-mediated apoptosis and cytolysis, by blocking the perforin/granzyme pathway.

Authors:  Dianzhong Luo; David Vermijlen; Peter JK Kuppen; Eddie Wisse
Journal:  Comp Hepatol       Date:  2002-11-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.